Melanopsin-expressing retinal ganglion cells: Implications for human diseases

Vision Research

Volumn 51, Issue 2, 2011, Pages 296-302

  La Morgia, Chiara ^a   Ross Cisneros, Fred N ^b   Hannibal, Jens ^c   Montagna, Pasquale ^a   Sadun, Alfredo A ^b   Carelli, Valerio ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Aging; Circadian; Hereditary optic neuropathies; Melanopsin; Mitochondria; Neurodegeneration

Indexed keywords

MELANIN; MELANOPSIN;

AGING; AUTOSOMAL DOMINANT OPTIC ATROPHY; BLINDNESS; BLUE LIGHT; CELL LOSS; CIRCADIAN RHYTHM; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE; GENERAL ASPECTS OF DISEASE; GENETIC VARIABILITY; GLAUCOMA; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; MELANOPSIN GENE; MIGRAINE; NONHUMAN; OPTIC NERVE DISEASE; PATHOGENESIS; PHOTOPHOBIA; PHOTORECEPTOR; PHOTOTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA DISEASE; RETINA GANGLION CELL; REVIEW; SEASONAL AFFECTIVE DISORDER; SLEEP DISORDER; VISUAL DISCRIMINATION;

HUMANS; MITOCHONDRIAL DISEASES; PHOTOPHOBIA; RETINAL DISEASES; RETINAL GANGLION CELLS; ROD OPSINS; SEASONAL AFFECTIVE DISORDER; VISUAL PATHWAYS;

EID: 78651501512     PISSN: 00426989     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.visres.2010.07.023     Document Type: Review

References (114)

1. Archibald N.K., Clarke M.P., Mosimann U.P., Burn D.J. The retina in Parkinson's disease. Brain 2009, 132(Pt 5):1128-1145.
2. Atlasz T., Szabadfi K., Kiss P., Babai N., Koszegi Z., Tamas A., et al. PACAP-mediated neuroprotection of neurochemically identified cell types in MSG-induced retinal degeneration. Journal of Molecular Neuroscience 2008, 36(1-3):97-104.
3. Berisha F., Feke G.T., Trempe C.L., McMeel J.W., Schepens C.L. Retinal abnormalities in early Alzheimer's disease. Investigative Ophthalmology and Visual Science 2007, 48(5):2285-2289.
4. Berson D.M., Dunn F.A., Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science 2002, 295(5557):1070-1073.
5. Berson D.M. Strange vision: Ganglion cells as circadian photoreceptors. Trends in Neurosciences 2003, 26(6):314-320.
6. Bodis-Wollner I. Retinopathy in Parkinson disease. Journal of Neural Transmission 2009, 116(11):1493-1501.
7. Bose S., Dhillon N., Ross-Cisneros F.N., Carelli V. Relative post-mortem sparing of afferent pupil fibers in a patient with 3460 Leber's hereditary optic neuropathy. Graefes Archive for Clinical and Experimental Ophthalmology 2005, 243(11):1175-1179.
8. Brainard G.C., Hanifin J.P., Greeson J.M., Byrne B., Glickman G., Gerner E., et al. Action spectrum for melatonin regulation in humans: Evidence for a novel circadian photoreceptor. Journal of Neuroscience 2001, 21(16):6405-6412.
9. Bremner F.D., Tomlin E.A., Shallo-Hoffmann J., Votruba M., Smith S.E. The pupil in dominant optic atrophy. Investigative Ophthalmology and Visual Science 2001, 42(3):675-678.
10. Brown, T. M., Gigg, J., Piggins, H. D., & Lucas, R. J. (2010). Melanopsin-dependent activation of dorsal lateral geniculate neurons. ARVO 2010, poster no. 672/D736.
11. Burns A., Allen H., Tomenson B., Duignan D., Byrne J. Bright light therapy for agitation in dementia: A randomized controlled trial. International Psychogeriatrics 2009, 21(4):711-721.
12. Cajochen C., Münch M., Knoblauch V., Blatter K., Wirz-Justice A. Age-related changes in the circadian and homeostatic regulation of human sleep. Chronobiology International 2006, 23(1-2):461-474.
13. Carelli V., La Morgia C., Iommarini L., Carroccia R., Mattiazzi M., Sangiorgi S., et al. Mitochondrial optic neuropathies: How two genomes may kill the same cell type?. Bioscience Reports 2007, 27(1-3):173-184.
14. Carelli V., Ross-Cisneros F.N., Sadun A.A. Mitochondrial dysfunction as a cause of optic neuropathies. Progress in Retinal and Eye Research 2004, 23:53-89.
15. Carrier J., Paquet J., Morettini J., Touchette E. Phase advance of sleep and temperature circadian rhythms in the middle years of life in humans. Neuroscience Letters 2002, 320(1-2):1-4.
16. Chakravarthy U., Evans J., Rosenfeld P.J. Age related macular degeneration. BMJ 2010, 340:c981.
17. Chambille I., Serviere J. Neurotoxic effects of neonatal injections of monosodium l-glutamate (l-MSG) on the retinal ganglion cell layer of the golden hamster: Anatomical and functional consequences on the circadian system. Journal of Comparative Neurology 1993, 338:67-82.
18. Chen, S. -K., Ecker, J. L., & Hattar, S. (2010). Understanding the complexity of ipRGCs targeting and functions. ARVO meeting, poster no. 664/D728.
19. Cooper H.M., Herbin M., Nevo E. Ocular regression conceals adaptive progression of the visual system in a blind subterranean mammal. Nature 1993, 361(6408):156-159.
20. Cooper, H. M., Drouyer, E., Dkhissi-Benyahya, O., Gronfier, C., Chiquet, C., WoldeMussie, E., et al. (2008). Effects of glaucoma on the circadian timing system in mice and men. ARVO meeting, poster no. 182/A327.
21. Czeisler C.A., Shanahan T.L., Klerman E.B., Martens H., Brotman D.J., Emens J.S., et al. Suppression of melatonin secretion in some blind patients by exposure to bright light. New England Journal of Medicine 1995, 332(1):6-11.
22. Dacey D.M., Liao H.W., Peterson B.B., Robinson F.R., Smith V.C., Pokorny J., et al. Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN. Nature 2005, 433(7027):749-754.
23. David-Gray Z.K., Janssen J.W., DeGrip W.J., Nevo E., Foster R.G. Light detection in a 'blind' mammal. Nature Neuroscience 1998, 1(8):655-656.
24. Dijk D.J., Duffy J.F., Czeisler C.A. Contribution of circadian physiology and sleep homeostasis to age-related changes in human sleep. Chronobiology International 2000, 17(3):285-311.
25. Dijk D.J., Archer S.N. Light, sleep, and circadian rhythms: Together again. PLoS Biology 2009, 7(6):e1000145.
26. Dowling G.A., Burr R.L., Van Someren E.J., Hubbard E.M., Luxenberg J.S., Mastick J., et al. Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease. Journal of the American Geriatrics Society 2008, 56(2):239-246.
27. Drouyer E., Dkhissi-Benyahya O., Chiquet C., WoldeMussie E., Ruiz G., Wheeler L.A., et al. Glaucoma alters the circadian timing system. PLoS ONE 2008, 3(12):e3931.
28. Esquiva, G., Gonzalez-Mendez, I., Fernandez-Sanchez, L., Garcia-Martin, E., Pinilla, I., Garcia-Fernandez, J., et al. (2010). Degeneration of melanopsin photosensitive retinal ganglion cells in human retinas with aging and in animal models of retinitis pigmentosa. ARVO meeting, poster no. 680/D744.
29. Foster R.G., Provencio I., Hudson D., Fiske S., De Grip W., Menaker M. Circadian photoreception in the retinally degenerate mouse (rd/rd). Journal of Comparative Physiology A 1991, 169(1):39-50.
30. Freedman M.S., Lucas R.J., Soni B., von Schantz M., Muñoz M., David-Gray Z., et al. Regulation of mammalian circadian behavior by non-rod, non-cone, ocular photoreceptors. Science 1999, 284(5413):502-504.
31. Fu Y., Zhong H., Wang M.H., Luo D.G., Liao H.W., Maeda H., et al. Intrinsically photosensitive retinal ganglion cells detect light with a vitamin A-based photopigment, melanopsin. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(29):10339-11044.
32. Gias, C., Semo, M., Vugler, A. A., & Coffey, P. J. (2010). Melanopsin cortical response in the rodless coneless mouse to light stimulation revealed using optical imaging of intrinsic signals. ARVO meeting, poster no. 673/D737.
33. Glickman G., Byrne B., Pineda C., Hauck W.W., Brainard G.C. Light therapy for seasonal affective disorder with blue narrow-band light-emitting diodes (LEDs). Biological Psychiatry 2006, 59(6):502-507.
34. Guler A.D., Ecker J.L., Lall G.S., Haq S., Altimus C.M., Liao H.W., et al. Melanopsin cells are the principal conduits for rod-cone input to non-image-forming vision. Nature 2008, 453:102-105.
35. Hannibal J., Vrang N., Card J.P., Fahrenkrug J. Light-dependent induction of cFos during subjective day and night in PACAP-containing ganglion cells of the retinohypothalamic tract. Journal of Biological Rhythms 2001, 16:457-470.
36. Hannibal J., Hindersson P., Knudsen S.M., Georg B., Fahrenkrug J. The photopigment melanopsin is exclusively present in PACAP containing retinal ganglion cells of the retinohypothalamic tract. Journal of Neuroscience 2002, 22(RC191):1-7.
37. Hannibal J., Hindersson P., Nevo E., Fahrenkrug J. The circadian photopigment melanopsin is expressed in the blind subterranean mole rat, Spalax. NeuroReport 2002, 13(11):1411-1414.
38. Hannibal J., Hindersson P., Ostergaard J., Georg B., Heegaard S., Larsen P.J., et al. Melanopsin is expressed in PACAP-containing retinal ganglion cells of the human retinohypothalamic tract. Investigative Ophthalmology and Visual Science 2004, 45(11):4202-4209.
39. Hannibal J., Fahrenkrug J. Melanopsin containing retinal ganglion cells are light responsive from birth. Neuroreport 2004, 15(15):2317-2320.
40. Hannibal J., Fahrenkrug J. Neuronal input pathways to the brain's biological clock and their functional significance. Advances in Anatomy, Embryology and Cell Biology 2006, 182:1-71.
41. Hartwick A.T., Bramley J.R., Yu J., Stevens K.T., Allen C.N., Baldridge W.H., et al. Light-evoked calcium responses of isolated melanopsin-expressing retinal ganglion cells. Journal of Neuroscience 2007, 27(49):13468-13480.
42. Hätönen T., Laakso M.L., Heiskala H., Alila-Johansson A., Sainio K., Santavuori P. Bright light suppresses melatonin in blind patients with neuronal ceroid-lipofuscinoses. Neurology 1998, 50(5):1445-1450.
43. Hatori M., Le H., Vollmers C., Keding S.R., Tanaka N., Schmedt C., et al. Inducible ablation of melanopsin-expressing retinal ganglion cells reveals their central role in non-image forming visual responses. PLoS ONE 2008, 3:e2451.
44. Hattar S., Liao H.W., Takao M., Berson D.M., Yau K.W. Melanopsin-containing retinal ganglion cells: Architecture, projections, and intrinsic photosensitivity. Science 2002, 295(5557):1065-1070.
45. Hattar S., Kumar M., Park A., Tong P., Tung J., Yau K.W., et al. Central projections of melanopsin-expressing retinal ganglion cells in the mouse. Journal of Comparative Neurology 2006, 497(3):326-349.
46. Hendrickson A.E., Wagoner N., Cowan W.M. An autoradiographic and electron microscopic study of retino-hypothalamic connections. Zeitschrift für Zellforschung und Mikroskopische Anatomie 1972, 135:1-26.
47. Hinton D.R., Sadun A.A., Blanks J.C., Miller C.A. Optic-nerve degeneration in Alzheimer's disease. New England Journal of Medicine 1986, 315(8):485-487.
48. Jakobs T.C., Libby R.T., Ben Y., John S.W., Masland R.H. Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. Journal of Cell Biology 2005, 171(2):313-325.
49. Jean-Louis G., Zizi F., Lazzaro D.R., Wolintz A.H. Circadian rhythm dysfunction in glaucoma: A hypothesis. J Circadian Rhythms 2008, 10(6):1.
50. Johnson B.M., Miao M., Sadun A.A. Age-related decline of human optic nerve axon populations. Age 1987, 10:5-9.
51. Jusuf P.R., Lee S.C., Hannibal J., Grünert U. Characterization and synaptic connectivity of melanopsin-containing ganglion cells in the primate retina. European Journal of Neuroscience 2007, 26(10):2906-2921.
52. Kalaboukhova L., Fridhammar V., Lindblom B. Relative afferent pupillary defect in glaucoma: A pupillometric study. Acta Ophthalmologica Scandinavica 2007, 85(5):519-525.
53. Kawasaki A., Herbst K., Sander B., Milea D. Selective wavelength pupillometry in Leber hereditary optic neuropathy. Clinical and Experimental Ophthalmology 2010, 38(3):322-324.
54. Kumbalasiri T., Rollag M.D., Isoldi M.C., Castrucci A.M., Provencio I. Melanopsin triggers the release of internal calcium stores in response to light. Photochemistry and Photobiology 2007, 83(2):273-279.
55. La Morgia C., Ross-Cisneros F.N., Sadun A.A., Hannibal J., Munarini A., Mantovani V., et al. Melanopsin retinal ganglion cells are resistant to neurodegeneration in mitochondrial optic neuropathies. Brain 2010, 133:2426-2438.
56. Lewy A.J. Circadian misalignment in mood disturbances. Current Psychiatry Reports 2009, 11(6):459-465.
57. Lewy A.J., Emens J.S., Songer J.B., Sims N., Laurie A.L., Fiala S.C., et al. Winter depression: Integrating mood, circadian rhythms, and the sleep/wake and light/dark cycles into a bio-psycho-social-environmental model. Sleep Medicine Clinics 2009, 4(2):285-299.
58. Li R.S., Chen B.Y., Tay D.K., Chan H.H., Pu M.L., So K.F. Melanopsin-expressing retinal ganglion cells are more injury-resistant in a chronic ocular hypertension model. Investigative Ophthalmology and Visual Science 2006, 47(7):2951-2958.
59. Li S.Y., Yau S.Y., Chen B.Y., Tay D.K., Lee V.W., Pu M.L., et al. Enhanced survival of melanopsin-expressing retinal ganglion cells after injury is associated with the PI3 K/Akt pathway. Cellular and Molecular Neurobiology 2008, 28(8):1095-1107.
60. Lin B., Koizumi A., Tanaka N., Panda S., Masland R.H. Restoration of visual function in retinal degeneration mice by ectopic expression of melanopsin. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(41):16009-16014.
61. Lucas R.J., Freedman M.S., Muñoz M., Garcia-Fernández J.M., Foster R.G. Regulation of the mammalian pineal by non-rod, non-cone, ocular photoreceptors. Science 1999, 284(5413):505-507.
62. Lucas R.J., Hattar S., Takao M., Berson D.M., Foster R.G., Yau K.W. Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice. Science 2003, 299:245-247.
63. Lupi D., Oster H., Thompson S., Foster R.G. The acute light-induction of sleep is mediated by OPN4-based photoreception. Nature Neuroscience 2008, 11(9):1068-1073.
64. Matynia, A., Parikh, S., Chen, B., Nusinowitz, S., & Gorin, M. B. (2010). Behavioral and pharmacological analysis of light associated allodynia. ARVO meeting, poster no. 675/D739.
65. Mongrain V., Carrier J., Dumont M. Circadian and homeostatic sleep regulation in morningness-eveningness. Journal of Sleep Research 2006, 15(2):162-166.
66. Mongrain V., Dumont M. Increased homeostatic response to behavioral sleep fragmentation in morning types compared to evening types. Sleep 2007, 30(6):773-780.
67. Moore R.Y., Lenn N.J. A retinohypothalamic projection in the rat. Journal of Comparative Neurology 1972, 146:1-14.
68. Morgenthaler T.I., Lee-Chiong T., Alessi C., Friedman L., Aurora R.N., Boehlecke B., et al. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American academy of sleep medicine report. Standards of practice committee of the American academy of sleep medicine. Sleep 2007, 30(11):1445-1459.
69. Mure L.S., Rieux C., Hattar S., Cooper H.M. Melanopsin-dependent nonvisual responses: Evidence for photopigment bistability in vivo. Journal of Biological Rhythms 2007, 22(5):411-424.
70. Noseda R., Kainz V., Jakubowski M., Gooley J.J., Saper C.B., Digre K., et al. A neural mechanism for exacerbation of headache by light. Nature Neuroscience 2010, 13(2):239-245.
71. Osborne N.N., Li G.Y., Ji D., Mortiboys H.J., Jackson S. Light affects mitochondria to cause apoptosis to cultured cells: Possible relevance to ganglion cell death in certain optic neuropathies. Journal of Neurochemistry 2008, 105:2013-2028.
72. Park, J. C., Moura, A. L., Raza, A. S., Palmer, N., Gavazi, E., Tsang, S. H., et al. (2010). Toward a clinical protocol for assessing rod, cone and melanopsin contributions to the human pupil response. ARVO meeting, poster no. 1453/A602.
73. Paus S., Schmitz-Hübsch T., Wüllner U., Vogel A., Klockgether T., Abele M. Bright light therapy in Parkinson's disease: A pilot study. Movement Disorders 2007, 22(10):1495-1498.
74. Peirson S.N., Halford S., Foster R.G. The evolution of irradiance detection: Melanopsin and the non-visual opsins. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 2009, 364(1531):2849-2865.
75. Pérez-Rico C., de la Villa P., Blanco R., Germain F., Paz-Moreno J., Arribas-Gómez I. Alterations in nocturnal melatonin secretion in patients with optic neuropathies. Archivos de la Sociedad Espanola de Oftalmologia 2009, 84(5):251-257.
76. Perez Rico, C., de la Villa, P., & Blanco, R. (2010). Multifocal erg and light-induced melatonin suppression evaluation of the functional integrity of the retinohypothalamic tract in advanced glaucoma. ARVO 2010, poster no. 5490/A545.
77. Porcelli A.M., Angelin A., Ghelli A., Mariani E., Martinuzzi A., Carelli V., et al. Respiratory complex I dysfunction due to mitochondrial DNA mutations shifts the voltage threshold for opening of the permeability transition pore toward resting levels. Journal of Biological Chemistry 2009, 284(4):2045-2052.
78. Provencio I., Rodriguez I.R., Jiang G., Hayes W.P., Moreira E.F., Rollag M.D. A novel human opsin in the inner retina. Journal of Neuroscience 2000, 20(2):600-605.
79. Provencio I., Rollag M.D., Castrucci A.M. Photoreceptive net in the mammalian retina. This mesh of cells may explain how some blind mice can still tell day from night. Nature 2002, 415(6871):493.
80. Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology 2006, 90(3):262-267.
81. Reppert S.M., Weaver D.R. Coordination of circadian timing in mammals. Nature 2002, 418(6901):935-941.
82. Robinson G.A., Madison R.D. Axotomized mouse retinal ganglion cells containing melanopsin show enhanced survival, but not enhanced axon regrowth into a peripheral nerve graft. Vision Research 2004, 44(23):2667-2674.
83. Roecklein K.A., Rohan K.J., Duncan W.C., Rollag M.D., Rosenthal N.E., Lipsky R.H., et al. A missense variant (P10L) of the melanopsin (OPN4) gene in seasonal affective disorder. Journal of Affective Disorders 2009, 114(1-3):279-285.
84. Roenneberg T., Kuehnle T., Juda M., Kantermann T., Allebrandt K., Gordijn M., et al. Epidemiology of the human circadian clock. Sleep Medicine Reviews 2007, 11(6):429-438.
85. Sack R.L., Lewy A.J. Circadian rhythm sleep disorders: Lessons from the blind. Sleep Medicine Reviews 2001, 5(3):189-206.
86. Sadun A.A., Schaechter J.D., Smith L.E. A retinohypothalamic pathway in man: Light mediation of circadian rhythms. Brain Research 1984, 302(2):371-377.
87. Sadun A.A., Win P.H., Ross-Cisneros F.N., Walker S.O., Carelli V. Leber's hereditary optic neuropathy differentially affects smaller axons in the optic nerve. Transactions of the American Ophthalmological Society 2000, 98:223-232.
88. Saper C.B., Lu J., Chou T.C., Gooley J. The hypothalamic integrator for circadian rhythms. Trends in Neurosciences 2005, 28:152-157.
89. Seki T., Itoh H., Nakamachi T., Shioda S. Suppression of ganglion cell death by PACAP following optic nerve transection in the rat. Journal of Molecular Neuroscience 2008, 36(1-3):57-60.
90. Seki T., Itoh H., Nakamachi T., Endo K., Wada Y., Nakamura K., et al. Suppression of rat retinal ganglion cell death by PACAP following transient ischemia induced by high intraocular pressure. Journal of Molecular Neuroscience 2010, (June 29). (Epub ahead of print).
91. Semo M., Lupi D., Peirson S.N., Butler J.N., Foster R.G. Light-induced c-fos in melanopsin retinal ganglion cells of young and aged rodless/coneless (rd/rd cl) mice. European Journal of Neuroscience 2003, 18(11):3007-3017.
92. Semo M., Vugler A.A., Jeffery G. Paradoxical opsin expressing cells in the inner retina that are augmented following retinal degeneration. European Journal of Neuroscience 2007, 25(8):2296-2306.
93. Semo, M., Gias, C., Lawrence, J. M., Ahmado, A., Coffey, P. J., & Vugler, A. A. (2010). Melanopsin mediated photophobia in adult rodless and coneless mice. ARVO 2010, poster no. 674/D738.
94. Skene D.J., Arendt J. Circadian rhythm sleep disorders in the blind and their treatment with melatonin. Sleep Medicine 2007, 8(6):651-655.
95. Tarttelin E.E., Bellingham J., Bibb L.C., Foster R.G., Hankins M.W., Gregory-Evans K., et al. Expression of opsin genes early in ocular development of humans and mice. Experimental Eye Research 2003, 76(3):393-396.
96. Thapan K., Arendt J., Skene D.J. An action spectrum for melatonin suppression: Evidence for a novel non-rod, non-cone photoreceptor system in humans. Journal of Physiology 2001, 535(Pt. 1):261-267.
97. Trifunovic A., Larsson N.G. Mitochondrial dysfunction as a cause of ageing. Journal of Internal Medicine 2008, 263(2):167-178.
98. Tsai J.W., Hannibal J., Hagiwara G., Colas D., Ruppert E., Ruby N.F., et al. Melanopsin as a sleep modulator: Circadian gating of the direct effects of light on sleep and altered sleep homeostasis in Opn4(-/-) mice. PLoS Biology 2009, 7(6):e1000125.
99. Tu D.C., Zhang D., Demas J., Slutsky E.B., Provencio I., Holy T.E., et al. Physiologic diversity and development of intrinsically photosensitive retinal ganglion cells. Neuron 2005, 48(6):987-999.
100. Turner P.L., Mainster M.A. Circadian photoreception: Ageing and the eye's important role in systemic health. British Journal of Ophthalmology 2008, 92(11):1439-1444.
101. Vandewalle G., Maquet P., Dijk D.J. Light as a modulator of cognitive brain function. Trends in Cognitive Sciences 2009, 13(10):429-438.
102. Vandewalle G., Schmidt C., Albouy G., Sterpenich V., Darsaud A., Rauchs G., et al. Brain responses to violet, blue, and green monochromatic light exposures in humans: Prominent role of blue light and the brainstem. PLoS One 2007, 2(11):e1247.
103. Vandewalle G., Gais S., Schabus M., Balteau E., Carrier J., Darsaud A., et al. Wavelength-dependent modulation of brain responses to a working memory task by daytime light exposure. Cerebral Cortex 2007, 17(12):2788-2795.
104. von Bussmann K.A., Garey L.J., Jen L.S. Injury-resistant retinal ganglion cells that are rich in cytochrome oxidase. NeuroReport 1993, 4(3):247-250.
105. Vugler A.A., Redgrave P., Semo M., Lawrence J., Greenwood J., Coffey P.J. Dopamine neurones form a discrete plexus with melanopsin cells in normal and degenerating retina. Experimental Neurology 2007, 205(1):26-35.
106. Vugler A.A., Semo M., Joseph A., Jeffery G. Survival and remodeling of melanopsin cells during retinal dystrophy. Visual Neuroscience 2008, 25(2):125-138.
107. Wakakura M., Yokoe J. Evidence for preserved direct pupillary light response in Leber's hereditary optic neuropathy. British Journal of Ophthalmology 1995, 79(5):442-446.
108. Wang H.Z., Lu Q.J., Wang N.L., Liu H., Zhang L., Zhan G.L. Loss of melanopsin-containing retinal ganglion cells in a rat glaucoma model. Chinese Medical Journal (English Edition) 2008, 121(11):1015-1019.
109. Wee R., Van Gelder R.N. Sleep disturbances in young subjects with visual dysfunction. Ophthalmology 2004, 111(2):297-302.
110. Willis G.L., Kelly A.M., Kennedy G.A. Compromised circadian function in Parkinson's disease: Enucleation augments disease severity in the unilateral model. Behavioural Brain Research 2008, 193(1):37-47.
111. Wu Y.H., Swaab D.F. Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer's disease. Sleep Medicine 2007, 8(6):623-636.
112. Zaidi F.H., Hull J.T., Peirson S.N., Wulff K., Aeschbach D., Gooley J.J., et al. Short-wavelength light sensitivity of circadian, pupillary, and visual awareness in humans lacking an outer retina. Current Biology 2007, 17(24):2122-2128.
113. Zanna C., Ghelli A., Porcelli A.M., Karbowski M., Youle R.J., Schimpf S., et al. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain 2008, 131(Pt. 2):352-367.
114. Zhang X., Jones D., Gonzalez-Lima F. Neurodegeneration produced by rotenone in the mouse retina: A potential model to investigate environmental pesticide contributions to neurodegenerative diseases. Journal of Toxicology and Environmental Health, Part A 2006, 69(18):1681-1697.